Literature DB >> 18840492

Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice.

Z Sinkorová1, J Capková, J Niederlová, R Stepánková, J Sinkora.   

Abstract

Joint disease ankylosing enthesopathy (ANKENT) naturally occurs in inbred mice with C57Bl/10 genetic background. ANKENT has many parallels to human ankylosing spondylitis (AS) and represents an animal model for AS. Environmental conditions (i.e., microbial load of the organism) are among the risk factors for ANKENT, similar to AS. The role of microflora in the development of ANKENT was investigated. ANKENT was tested in four experimental groups of germ-free mice associated with different numbers of various intestinal microbes and three control groups: germ-free, specific pathogen-free, and conventional (CV) mice. Mice were colonized either with anaerobic bacteria isolated from the intestine of a CV mouse or with bacterial strains obtained from the collection of microorganisms. Microbes were characterized and checked by microbiological cultivation methods and with the use of polymerase chain reaction amplification and rDNA sequence analysis. Joint disease developed in GF mice colonized with a mixture containing Bacteroides spp. and Enterococcus sp., and/or Veillonella sp. and Staphylococcus sp. No ANKENT appeared in males colonized with probiotic bacterium Lactobacillus sp. In control groups ANKENT occurred in SPF and CV animals; the GF animals remained healthy. The results confirmed that the germ-free conditions protect from joint inflammation, and thus microbes are necessary for ANKENT development. In colonized mice the ANKENT was triggered by luminal anaerobic bacteria, which are common components of intestinal microflora.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840492     DOI: 10.1016/j.humimm.2008.08.296

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  28 in total

Review 1.  The immune system and the gut microbiota: friends or foes?

Authors:  Nadine Cerf-Bensussan; Valérie Gaboriau-Routhiau
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

Review 2.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

Review 3.  Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Authors:  Julia Manasson; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

Review 4.  Influence of microbial environment on autoimmunity.

Authors:  Alexander V Chervonsky
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 5.  The microbiome and rheumatoid arthritis.

Authors:  Jose U Scher; Steven B Abramson
Journal:  Nat Rev Rheumatol       Date:  2011-08-23       Impact factor: 20.543

Review 6.  Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease.

Authors:  M A Atkinson; A Chervonsky
Journal:  Diabetologia       Date:  2012-08-09       Impact factor: 10.122

Review 7.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

Review 8.  The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 9.  Microbiota and autoimmunity.

Authors:  Alexander V Chervonsky
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

Review 10.  Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.

Authors:  Jose U Scher; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.